(Q34343294)

1 August 2017

1 reference

title

Intranasal vaccination against plague, tetanus and diphtheria (English)

1 reference

1 August 2017

Alpar HO

1

1 reference

1 August 2017

Eyles JE

series ordinal

2

1 reference

1 August 2017

Williamson ED

series ordinal

3

1 reference

1 August 2017

Somavarapu S

series ordinal

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

1 August 2017

published in

1 reference

1 August 2017

volume

51

1 reference

1 August 2017

issue

1-3

1 reference

1 August 2017

page(s)

173-201

1 reference

A surface protease and the invasive character of plague

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Yersiniosis. II: The pathogenesis of Yersinia infections

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Yersinia pestis--etiologic agent of plague

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Plague Immunization. I. Past and Present Trends

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Identification and mapping of the temperature-inducible, plasmid-encoded proteins of Yersinia spp

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Local and systemic immune response to a microencapsulated sub-unit vaccine for plague

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Approaches To New Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Adjuvants for human vaccines--current status, problems and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Prospects for the development of new vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Therapeutic effects of leuprorelin microspheres on endometriosis and uterine leiomyomata

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Immunological concepts of vaccine adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Adjuvant effect of biodegradable poly(DL-lactic acid) granules capable for antigen release following intraperitoneal injection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Fully mobilizing host defense: building better vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Potential of polymer microencapsulation technology for vaccine innovation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Biodegradable microparticles with different release profiles: effect on the immune response after a single administration via intranasal and intramuscular routes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Measurement of protein using bicinchoninic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Studies on the co-encapsulation, release and integrity of two subunit antigens: rV and rF1 from Yersinia pestis.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Poly(L-lactide): a long-term degradation study in vivo. Part III. Analytical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Enteric immunization: promises and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Cellular and humoral responses to microencapsulated Yersinia pestis subunit vaccines following oral delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Nasal lymphoid tissue in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Antigen sampling across epithelial barriers and induction of mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Intranasal immunization with polymer-grafted microparticles activates the nasal-associated lymphoid tissue and draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Dry powder inhalation as a potential delivery method for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Local and systemic influenza haemagglutinin-specific antibody responses following aerosol and subcutaneous administration of inactivated split influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

The Lung as an Immunologic Organ

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

M cells at locations outside the gut.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

The role of M cells in mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Bronchus-associated lymphoid tissue (BALT) is not present in the normal adult lung but in different diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Tissue distribution of radioactivity following intranasal administration of radioactive microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Regional specialization in the mucosal immune system: primed cells do not always home along the same track

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Immunology of the tonsils.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Antibody responses and interferon titers in the respiratory tracts of mice after aerosolized exposure to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

IgG surfaces as an important component in mucosal protection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Protection studies following bronchopulmonary and intramuscular immunisation with yersinia pestis F1 and V subunit vaccines coencapsulated in biodegradable microspheres: a comparison of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

An apparatus for the study of airborne infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Immunoadjuvant action of liposomes: comparison with other adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Delivery of peptide and non-peptide drugs through the respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Effects of N-trimethyl chitosan chloride, a novel absorption enhancer, on caco-2 intestinal epithelia and the ciliary beat frequency of chicken embryo trachea

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Chitosan-mediated stimulation of macrophage function

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Effect of degree of quaternization of N-trimethyl chitosan chloride for enhanced transport of hydrophilic compounds across intestinal caco-2 cell monolayers.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Neutralization of diphtheria toxin by human immunoglobulin classes and subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Induction of systemic immune responses to measles virus synthetic peptides administered intranasally

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Screening of cationic compounds as an absorption enhancer for nasal drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Intranasal vaccination: pharmaceutical evaluation of the vaccine delivery system and immunokinetic characteristics of the immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Evaluation of local toxicity after repeated intranasal vaccination of guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Intranasal booster vaccination against diphtheria and tetanus in man

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Nasal and parenteral immunizations with diphtheria toxoid using monoglyceride/fatty acid lipid suspensions as adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Stealth PLA-PEG nanoparticles as protein carriers for nasal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Evaluation of the clearance characteristics of bioadhesive systems in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900166-1

7 January 2021

10.1016/S0169-409X(01)00166-1

Identifiers

DOI

1 reference

1 August 2017

1 reference